Yes of course it's a quality control issue and anyone knowing of the problem and how it would delay the release of news would have known it would lower somewhat the Noront market share price.

Can't be proven but sure looks like advantage was taken of information to sell Noront over past 2 weeks and due to the low volume of trading (while people waited for news) this ate away at share value so that when news did come about quality issues the price dropped even further. Not at all nice to experiance and does smack of manipulation/insider knowledge.

Genuity have a research report out on Noront with a 'BUY' recommendation (that is conservative in my opinion) and that's based on what was known about deposits before DE2 and DE3. Nothing has been released to change their opinion or mine. Until those assays or other good news (maybe visuals) come out in a news release we'll have to live with the Market not supporting Noront.

It's a fine time to buy which makes it tough on those of us who are already fully invested and patiently waiting for it to be a fine time to buy at $7 or $8.